Literature DB >> 19440017

A lower risk of dying from urological cancer in Down syndrome: clue for cancer protecting genes on chromosome 21.

Daniel Satgé1, Annie J Sasco, Steven Day, Stéphane Culine.   

Abstract

OBJECTIVE: It was the aim of this study to evaluate the risk of dying from bladder and kidney cancer in persons with Down syndrome (DS), as compared with the general population.
METHODS: Using data of the French national mortality statistics (INSERM) during a 21-year period, 1979-1999, we compared the observed number of deaths from renal and bladder cancer in DS subjects with the expected number of deaths from these cancers. The expected number of deaths was calculated taking into account the prevalence of DS at birth and the life expectancy of persons with DS, assuming the risk was identical to the one of the general population.
RESULTS: A significant 6-fold decreased risk of dying from urological cancer was found in persons with DS, with 5 cases observed, while 30 were expected. The relative risk of dying was 0.27 for bladder cancer (p = 0.0017) and 0.06 for kidney cancer (p < 0.0001). Other mortality studies provided similar values.
CONCLUSIONS: Children and adults with DS have a decreased risk of dying from urological neoplasms. Genes on chromosome 21 could play a protective role against urological cancer. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19440017     DOI: 10.1159/000209361

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Bladder cancer: a simple model becomes complex.

Authors:  Giovanni Battista Di Pierro; Caterina Gulia; Cristiano Cristini; Giorgio Fraietta; Lorenzo Marini; Pietro Grande; Vincenzo Gentile; Roberto Piergentili
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

2.  Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer.

Authors:  Ding-Zuan Zhang; Kin-Mang Lau; Eddie S Y Chan; Gang Wang; Cheuk-Chun Szeto; Kenneth Wong; Richard K W Choy; Chi-Fai Ng
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

3.  Low risk of solid tumors in persons with Down syndrome.

Authors:  Henrik Hasle; Jan M Friedman; Jørgen H Olsen; Sonja A Rasmussen
Journal:  Genet Med       Date:  2016-03-31       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.